◆ NeutralARDX
ARDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
GlobeNewswire Inc.·
Faruqi & Faruqi, LLP is investigating securities fraud claims against Ardelyx (NASDAQ: ARDX) for allegedly misleading investors about commercial performance of drugs XPHOZAH and IBSRELA and failing to disclose payer access barriers. The company reduced 2026 IBSRELA revenue guidance and withdrew XPHOZAH long-term guidance on August 6, 2026, causing stock to drop 18% in one day. Investors who purchased securities between January 13, 2025 and August 6, 2026 may be eligible to participate in the class action with a November 16, 2026 deadline to seek lead plaintiff status.
Read Full Article at GlobeNewswire Inc. →